Neuropsychological profile in patients with myotonic dystrophy type 1: a four-year follow-up study

被引:2
|
作者
Diaz-Leiva, Javier [1 ]
Cabada-Giadas, Teresa [2 ]
Seijas-Gomez, Raquel [1 ]
Jerico-Pascual, Ivonne [3 ]
Lopez-Sala, Paul [2 ]
Iridoy-Zulet, Marina [4 ]
机构
[1] Complejo Hosp Navarra, Red Salud Mental Navarra, Serv Navarro Salud Osasunbidea, Pamplona, Navarra, Spain
[2] Complejo Hosp Navarra, Serv Radiol, Irunlarrea 3, E-31008 Pamplona, Navarra, Spain
[3] Complejo Hosp Navarra, Serv Neurol, Pamplona, Navarra, Spain
[4] Hosp Zumarraga, Serv Neurol, Zumarraga, Guipuzcoa, Spain
关键词
Cognitive impairment; Dysexecutive syndrome; Myotonic dystrophy; Neurodegenerative pattern; Neuropsychological progress; DYSEXECUTIVE QUESTIONNAIRE DEX; COGNITIVE IMPAIRMENT; PSYCHOMETRIC PROPERTIES; SPANISH VERSION; DIAGNOSIS; SYMPTOMS; PATTERN; ADULTS;
D O I
10.33588/rn.7011.2019455
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Myotonic dystrophy type 1 (MD1), or Steinert's disease, is a multisystemic disorder of autosomal dominant inheritance, whose adult variant usually presents with multidomain cognitive impairment and affects patients' functionality and quality of life. Aim. To study the four-year history of cognitive functioning in a sample of patients with the adult variant of MD1. Patients and methods. The neurocognitive functions of a sample of 31 patients with MD1 are evaluated, of whom 24 repeat the test administered four years ago in the Neurology Service of the Complejo Hospitalario of Navarra. Data are collected from the cognitive domains that are most related to the deficits that usually present in MD1. Results. The follow-up evaluation found that the visuospatial and visuoconstructive functions and alternating attention of the patients who underwent the study were affected, as was their daily functioning reported by the family. These results are in line with those obtained four years earlier, with no significant deterioration observed between the two measurements. A higher incidence of cognitive impairment was also displayed in 2018, with some cases of progression to dementia in Steinert's disease. Conclusion. Neurocognitive progression in MD1 seems to respond to a progressive pattern of degeneration, linked to the functions that are most affected from the beginning of the sequelae phase and which usually correspond to the domains of working memory, alternating attention, and visuospatial and visuoconstructive abilities.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 50 条
  • [1] Longitudinal Changes in Neuropsychological Functioning in Japanese Patients with Myotonic Dystrophy Type 1: A Five Year Follow-Up Study
    Fujino, Haruo
    Suwazono, Shugo
    Ueda, Yukihiko
    Kobayashi, Michio
    Nakayama, Takahiro
    Imura, Osamu
    Matsumura, Tsuyoshi
    Takahashi, Masanori P.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (06) : 1083 - 1092
  • [2] Cognition in myotonic dystrophy type 1: a 5-year follow-up study
    Winblad, S.
    Samuelsson, L.
    Lindberg, C.
    Meola, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (09) : 1471 - 1476
  • [3] Masticatory dysfunction in patients with myotonic dystrophy (type 1): a 5-year follow-up
    Umemoto, George
    Nakamura, Hirokazu
    Oya, Yasushi
    Kikuta, Toshihiro
    SPECIAL CARE IN DENTISTRY, 2009, 29 (05) : 210 - 214
  • [4] Endocrine function in patients with myotonic dystrophy type 1-9 year follow-up
    Dahlqvist, J. R.
    Oerngreen, M. C.
    Witting, N.
    Vissing, J.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 834 - 834
  • [5] A descriptive study of the neuropsychological and psychopathological profile in patients with type 1 myotonic dystrophy
    Seijas-Gomez, Raquel
    Basterra-Jimenez, Izaskun
    Luna-Lario, Pilar
    Tirapu-Ustarroz, Javier
    Cabada-Giadas, Teresa
    Iridoy-Zulet, Marina
    Jerico-Pascual, Ivonne
    Gargallo-Vaamonde, Alvaro
    Javier Lopez-Goni, Jose
    REVISTA DE NEUROLOGIA, 2015, 61 (12) : 529 - 535
  • [6] Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A four-year follow-up study.
    Faraone, SV
    Seidman, LJ
    Kremen, WS
    Toomey, R
    Pepple, JR
    Tsuang, MT
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (06): : 597 - 597
  • [7] Tracking the brain in myotonic dystrophy: A 5-year longitudinal neuroimaging and neuropsychological follow-up study
    Merkel, C.
    Minnerop, M.
    Roeske, S.
    Gaertner, H.
    Schoene-Bake, J. C.
    Adler, S.
    Witt, J. A.
    Anspach, C.
    Schneider-Gold, C.
    Betz, R. C.
    Helmstaedter, C.
    Tittgemeyer, M.
    Amunts, K.
    Klockgether, T.
    Weber, B.
    Kornblum, C.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 839 - 840
  • [8] Comprehensive four-year disease progression assessment of myotonic dystrophy type 1
    la Fontaine, Leandre A.
    Bruijnes, Johanna E.
    Smulders, Fran H. P.
    Gorissen-Brouwers, Carla
    Karnebeek, Ilse E. A.
    Braakman, Hilde M. H.
    Klinkenberg, Sylvia
    Mul, Karlien
    Hoen, Peter-Bram A. C. 't
    van Kuijk, Sander M. J.
    van Engelen, Baziel G. M.
    Merkies, Ingemar S. J.
    Faber, Catharina G.
    NEUROMUSCULAR DISORDERS, 2024, 43 : 44 - 52
  • [9] Cognitive impairment in myotonic dystrophy type 1: a longitudinal follow-up study
    Modoni, A.
    Silvestri, G.
    Vita, M. G.
    Masciullo, M.
    Tonali, P. A.
    Ricci, E.
    Marra, C.
    JOURNAL OF NEUROLOGY, 2007, 254 : 154 - 154
  • [10] Natural progression of cardiac autonomic neuropathy in patients with type 1 diabetes: a four-year follow-up study
    Abd El Dayem, Soha M.
    Battah, Ahmed A.
    Soliman, Randa A.
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2011, 11 (03): : 224 - 231